Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,684 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $826.67 | 24 | $0 (2024) |
| Amgen Inc. | $438.02 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $311.44 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $241.11 | 12 | $0 (2023) |
| PFIZER PHARMACEUTICALS LLC | $238.72 | 8 | $0 (2019) |
| PBG PUERTO RICO LLC | $197.04 | 9 | $0 (2024) |
| Medtronic Vascular, Inc. | $118.07 | 1 | $0 (2020) |
| Boston Scientific Corporation | $109.37 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.00 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $62.05 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $378.15 | 12 | Boston Scientific Corporation ($109.37) |
| 2023 | $320.65 | 9 | E.R. Squibb & Sons, L.L.C. ($154.64) |
| 2022 | $200.08 | 6 | Janssen Pharmaceuticals, Inc ($99.97) |
| 2021 | $67.33 | 3 | Janssen Pharmaceuticals, Inc ($25.00) |
| 2020 | $375.90 | 8 | Amgen Inc. ($125.00) |
| 2019 | $396.83 | 16 | Janssen Pharmaceuticals, Inc ($163.76) |
| 2018 | $374.35 | 13 | Janssen Pharmaceuticals, Inc ($184.42) |
| 2017 | $570.47 | 15 | Janssen Pharmaceuticals, Inc ($204.57) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiovascular | ||||||
| 07/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Cardiology | ||||||
| 04/24/2024 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.18 | General |
| Category: Cardiovascular | ||||||
| 02/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Cardiology | ||||||
| 08/30/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.64 | General |
| Category: Cardiovascular | ||||||
| 08/25/2023 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 06/29/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 06/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DIABETES | ||||||
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2023 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 10/21/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Rare Disease | ||||||
| 08/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 06/29/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 48 | $2,987 | $2,028 |
| 2022 | 1 | 12 | 28 | $2,586 | $1,683 |
| 2021 | 2 | 28 | 47 | $2,961 | $2,110 |
| 2020 | 2 | 29 | 60 | $3,497 | $2,593 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 30 | $2,725 | $1,834 | 67.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 18 | $262.26 | $194.31 | 74.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 28 | $2,586 | $1,683 | 65.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 29 | $2,690 | $1,917 | 71.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 18 | $271.08 | $192.80 | 71.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 41 | $3,166 | $2,371 | 74.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 19 | $330.60 | $222.16 | 67.2% |
About Dianolis Trinidad
Dianolis Trinidad is a Cardiovascular Disease healthcare provider based in Bayamon, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104986322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dianolis Trinidad has received a total of $2,684 in payments from pharmaceutical and medical device companies, with $378.15 received in 2024. These payments were reported across 82 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,684).
As a Medicare-enrolled provider, Trinidad has provided services to 98 Medicare beneficiaries, totaling 183 services with total Medicare billing of $8,413. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Bayamon, PR
- Active Since 12/11/2006
- Last Updated 01/02/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104986322
Products in Payments
- XARELTO (Drug) $747.87
- ELIQUIS (Drug) $704.12
- Repatha (Biological) $438.02
- BRILINTA (Drug) $125.84
- CoreValve Evolut (Device) $118.07
- WATCHMAN FLX (Device) $109.37
- FARXIGA (Drug) $96.16
- JARDIANCE (Drug) $95.00
- ZYTIGA (Drug) $78.80
- LifeVest (Device) $62.05
- LINQ II (Device) $25.00
- CAMZYOS (Drug) $23.18
- ENTRESTO (Drug) $21.27
- VYNDAQEL (Drug) $19.90
- ANDEXXA (Biological) $19.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bayamon
Dr. Jose Novoa, M.d, M.D
Cardiovascular Disease — Payments: $412,359
Juan Igartua Ponton, M.d.f.a.c.c, M.D.F.A.C.C
Cardiovascular Disease — Payments: $58,670
Dr. Luis Molinary Fernandez, M.d, M.D
Cardiovascular Disease — Payments: $36,956
Dr. Domingo Perez, Md, MD
Cardiovascular Disease — Payments: $9,863
Jose Rodriguez Castro, Md, MD
Cardiovascular Disease — Payments: $4,818
Mr. Edwin Alejandro, Md, MD
Cardiovascular Disease — Payments: $4,567